Results 141 to 150 of about 27,772 (222)

Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era. [PDF]

Mycopathologia
Lopez CM, Suarez JF, Mendoza MA, Anderson AD, Lykon J, Li W, Morris MI, Natori Y, Raja M, Lekakis LJ, Beitinjaneh A, Jimenez A, Goodman M, Wang TP, Spiegel J, Holtzman NG, Pereira D, Green D, Komanduri KV, Camargo JF.   +19 more
europepmc   +1 more source

Description of invasive aspergillosis in Mexican patients with chronic granulomatous disease. [PDF]

J Hum Immun
Cova-Guzmán T, Palacios Reyes D, Román-Montes CM, Yamazaki-Nakashimada MA, Staines Boone AT, Silva-Goytia L, García-Cruz ML, Gómez-Tello H, Pérez-Blanco U, Jiménez-Polvo N, Mamani Velasquez E, Ramírez Uribe N, Medina Vera I, Espinosa Padilla S, Blancas-Galicia L.   +14 more
europepmc   +1 more source

Successful Long-Term Use of Isavuconazole in a Tacrolimus-Treated Japanese Kidney Transplant Recipient With Disseminated Cryptococcosis and Probable Invasive Aspergillosis. [PDF]

Cureus
Akagawa Y, Egawa N, Shimizu T, Shinkai Y, Ono S, Koga S, Ishikawa K.   +6 more
europepmc   +1 more source

Current Challenges in the Treatment of Invasive Aspergillosis in Geriatric Patients. [PDF]

J Fungi (Basel)
Fueyo Álvarez S, Calonge EV, Caballero Velasquez JA, Revelo Rueda AM, Solla Suarez PE, López Álvarez EM, Rodriguez Perez M, Peláez García de la Rasilla MT.   +7 more
europepmc   +1 more source

Value of plasma metagenomic next-generation sequencing for the diagnosis of invasive aspergillosis: a multicenter-center retrospective study. [PDF]

Front Cell Infect Microbiol
Wu X, Wang W, Xu L, Zhou W, Zhou J, Zhou H.   +5 more
europepmc   +1 more source

The therapeutic effect of 5-nitro-8-hydroxyquinoline on <i>Aspergillus fumigatus</i>: results from <i>in vitro</i> and <i>in vivo</i> models of invasive aspergillosis. [PDF]

Front Cell Infect Microbiol
Ran J, Zhou X, Gao Z, Huan X, Zeng M, Tu Z.   +5 more
europepmc   +1 more source

Refractory versus resistant invasive aspergillosis. [PDF]

J Antimicrob Chemother
Arendrup MC, Cordonnier C.
europepmc   +1 more source

Bruton tyrosine kinase inhibitors and invasive aspergillosis and mucormycosis: a case report and multi-center exploratory retrospective study. [PDF]

ASM Case Rep
Bhaimia E, Russell D, Santos CAQ.
europepmc   +1 more source

Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012-2018. [PDF]

Emerg Infect Dis
Bertin-Biasutto L, Paccoud O, Garcia-Hermoso D, Denis B, Boukris-Sitbon K, Lortholary O, Bretagne S, Gits-Muselli M, Herbrecht R, Letscher-Bru V, Danion F, Cassaing S, Morio F, Nourrisson C, Pihet M, Sasso M, Desoubeaux G, Durieux MF, Bonhomme J, Chachaty E, Chouaki T, Desbois-Nogard N, Alanio A, Gangneux JP, Lanternier F.   +24 more
europepmc   +1 more source

Is neutropenia still the main risk factor for invasive aspergillosis? A contemporary university hospital retrospective cohort of invasive aspergillosis in neutropenic and non-neutropenic patients. [PDF]

Ann Clin Microbiol Antimicrob
Gutiérrez-Villanueva A, Diego-Yagüe I, Gutiérrez-Martín I, García-Prieto S, Gutiérrez-Abreu E, Fernández-Guitián R, Castilla-Martínez I, Bermejo-Moreno N, Miguel-Ontañon N, Calderón-Parra J, Callejas-Díaz A, Díaz-de Santiago A, de la Fuente-Moral S, Múñez-Rubio E, García-Masedo S, Sánchez-Romero I, Ramos-Martínez A, Fernández-Cruz A.   +17 more
europepmc   +1 more source